239 related articles for article (PubMed ID: 25634208)
1. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.
Neskey DM; Osman AA; Ow TJ; Katsonis P; McDonald T; Hicks SC; Hsu TK; Pickering CR; Ward A; Patel A; Yordy JS; Skinner HD; Giri U; Sano D; Story MD; Beadle BM; El-Naggar AK; Kies MS; William WN; Caulin C; Frederick M; Kimmel M; Myers JN; Lichtarge O
Cancer Res; 2015 Apr; 75(7):1527-36. PubMed ID: 25634208
[TBL] [Abstract][Full Text] [Related]
2. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.
Osman AA; Neskey DM; Katsonis P; Patel AA; Ward AM; Hsu TK; Hicks SC; McDonald TO; Ow TJ; Alves MO; Pickering CR; Skinner HD; Zhao M; Sturgis EM; Kies MS; El-Naggar A; Perrone F; Licitra L; Bossi P; Kimmel M; Frederick MJ; Lichtarge O; Myers JN
Cancer Res; 2015 Apr; 75(7):1205-15. PubMed ID: 25691460
[TBL] [Abstract][Full Text] [Related]
4. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.
El Baroudi M; Machiels JP; Schmitz S
Cancer Biol Ther; 2017 Oct; 18(10):775-782. PubMed ID: 28886272
[TBL] [Abstract][Full Text] [Related]
5. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer.
Wichmann G; Rosolowski M; Krohn K; Kreuz M; Boehm A; Reiche A; Scharrer U; Halama D; Bertolini J; Bauer U; Holzinger D; Pawlita M; Hess J; Engel C; Hasenclever D; Scholz M; Ahnert P; Kirsten H; Hemprich A; Wittekind C; Herbarth O; Horn F; Dietz A; Loeffler M;
Int J Cancer; 2015 Dec; 137(12):2846-57. PubMed ID: 26095926
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Coaxum SD; Tiedeken J; Garrett-Mayer E; Myers J; Rosenzweig SA; Neskey DM
Oncotarget; 2017 Apr; 8(14):22991-23007. PubMed ID: 28160562
[TBL] [Abstract][Full Text] [Related]
7. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
Ganci F; Sacconi A; Bossel Ben-Moshe N; Manciocco V; Sperduti I; Strigari L; Covello R; Benevolo M; Pescarmona E; Domany E; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
Ann Oncol; 2013 Dec; 24(12):3082-8. PubMed ID: 24107801
[TBL] [Abstract][Full Text] [Related]
8. A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
Shi C; Liu S; Tian X; Wang X; Gao P
BMC Cancer; 2021 Sep; 21(1):1035. PubMed ID: 34530752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma.
Lindenbergh-van der Plas M; Brakenhoff RH; Kuik DJ; Buijze M; Bloemena E; Snijders PJ; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2011 Jun; 17(11):3733-41. PubMed ID: 21467160
[TBL] [Abstract][Full Text] [Related]
10. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.
Lee TL; Yang XP; Yan B; Friedman J; Duggal P; Bagain L; Dong G; Yeh NT; Wang J; Zhou J; Elkahloun A; Van Waes C; Chen Z
Clin Cancer Res; 2007 Oct; 13(19):5680-91. PubMed ID: 17908957
[TBL] [Abstract][Full Text] [Related]
11. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection.
Klinakis A; Rampias T
EBioMedicine; 2020 Aug; 58():102905. PubMed ID: 32739866
[TBL] [Abstract][Full Text] [Related]
13. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
[TBL] [Abstract][Full Text] [Related]
14. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
[TBL] [Abstract][Full Text] [Related]
15. Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non-small cell lung cancer.
Jiang W; Cheng H; Yu L; Zhang J; Wang Y; Liang Y; Lou F; Wang H; Cao S
Cancer Med; 2023 Mar; 12(6):6649-6658. PubMed ID: 36440695
[TBL] [Abstract][Full Text] [Related]
16. [High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].
Fogel S; Ahomadegbe JC; Barrois M; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
Bull Cancer; 1996 Mar; 83(3):227-33. PubMed ID: 8695925
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
[TBL] [Abstract][Full Text] [Related]
18. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.
Sano D; Xie TX; Ow TJ; Zhao M; Pickering CR; Zhou G; Sandulache VC; Wheeler DA; Gibbs RA; Caulin C; Myers JN
Clin Cancer Res; 2011 Nov; 17(21):6658-70. PubMed ID: 21903770
[TBL] [Abstract][Full Text] [Related]
19. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in head and neck cancer.
Perrone F; Bossi P; Licitra L
N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
